Natco Pharma

Natco Pharma receives EIR from US FDA

Read more

USFDA inspection at Chennai facility ends with zero observations: Natco Pharma

Read more

Panel discussion: From formulation development to commercialisation of complex generics: Challenges and mitigation strategies

Read more

Natco gets US FDA nod to market renal disease drug

Read more

Natco Pharma CEO supports children’s eye care at LV Prasad Eye Institute

Read more

Natco Pharma to sell US-based pharmacy stores

Read more

NATCO receives DCG(I) approval for hepatitis C drug

Read more

Natco settles patent suit with Gilead, others

Read more

Natco Pharma suspends work at Chennai plant due to flood

Read more

NATCO launches hepatitis C drug in Nepal

Read more